Donate Help Contact The AHA Sign In Home
American Heart Association
Circulation
Search: search_blue_button Advanced Search
Circulation. 2008;117:2369-2376
Published online before print April 28, 2008, doi: 10.1161/CIRCULATIONAHA.107.739888
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Data Supplement
Right arrow All Versions of this Article:
117/18/2369    most recent
CIRCULATIONAHA.107.739888v1
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow Request Permissions
Google Scholar
Right arrow Articles by Duez, H.
Right arrow Articles by Lewis, G. F.
PubMed
Right arrow PubMed Citation
Right arrow Articles by Duez, H.
Right arrow Articles by Lewis, G. F.
Right arrowPubmed/NCBI databases
*Substance via MeSH
Related Collections
Right arrow Lipid and lipoprotein metabolism
Right arrowRelated Article

(Circulation. 2008;117:2369-2376.)
© 2008 American Heart Association, Inc.


Vascular Medicine

Both Intestinal and Hepatic Lipoprotein Production Are Stimulated by an Acute Elevation of Plasma Free Fatty Acids in Humans

Hélène Duez, PhD; Benoît Lamarche, PhD; René Valéro, MD, PhD; Mirjana Pavlic, MD; Spencer Proctor, PhD; Changting Xiao, PhD; Linda Szeto, MSc; Bruce W. Patterson, PhD; Gary F. Lewis, MD

From the Departments of Medicine and Physiology, Division of Endocrinology and Metabolism, University of Toronto, Toronto, Canada (H.D., R.V., M.P., C.X., L.S., G.F.L.); Institut des Nutraceutiques et aliments fonctionnels, Université Laval, Québec, Canada (B.L.); Alberta Institute for Human Nutrition, University of Alberta, Edmonton, Alberta, Canada (S.P.); and Department of Internal Medicine, Washington University School of Medicine, St Louis, Mo (B.W.P.).

Correspondence to Dr Gary F. Lewis, Toronto General Hospital, 200 Elizabeth St, EN12-218, Toronto, Ontario, M5G 2C4, Canada. E-mail gary.lewis{at}uhn.on.ca

Received September 14, 2007; accepted February 15, 2008.

Background— Hepatic lipoprotein production has been shown previously to be regulated by free fatty acid (FFA) flux to the liver, whereas intestinal lipoprotein production is stimulated mainly by ingested fat absorbed from the intestinal lumen. Emerging evidence indicates that intestinal lipoprotein production is increased in insulin resistance and type 2 diabetes mellitus, conditions that are associated with increased levels of circulating FFAs. Here we investigated whether short-term elevation of plasma FFAs stimulates intestinal apolipoprotein (apo) B-48– and hepatic apoB-100–containing triglyceride-rich lipoprotein (TRL) production in humans in the fed state.

Methods and Results— TRL apoB-48 and apoB-100 metabolism were examined in 12 healthy men during a constant fed state. The studies were as follows, respectively: (1) Intralipid/heparin was infused intravenously immediately before and during the kinetics study to induce an {approx}3-fold difference in plasma FFA compared with the saline study; (2) saline was infused intravenously as a control. ApoB-48– and apoB-100–containing TRL production and clearance were determined with a 12-hour primed constant infusion of [D3]L-leucine and multicompartmental kinetic modeling. TRL apoB-48 production rate was 69% higher in the Intralipid/heparin study than in the saline control (5.95±1.13 versus 3.53±0.58 mg/kg per day; P=0.027), and there was no significant difference in TRL apoB-48 clearance. TRL apoB-100 concentrations were also increased (P<0.001) and TRL apoB-100 production rate was 35% higher in the Intralipid/heparin study compared with saline (28±4 versus 21±3 mg/kg per day; P=0.020).

Conclusions— This is the first study to demonstrate that intestinal TRL apoB-48 production is increased after short-term elevation of plasma FFAs in humans in the fed state, similar to the well-described stimulation of hepatic TRL apoB100–containing particles by FFAs.


 

CLINICAL PERSPECTIVE


Related Article:

Clinical Summaries
Circulation 2008 117: 2309-2310. [Full Text]